Eurofins Scientific SE (ESF0) — Capital Reinvestment Ratio

Latest as of December 2022: 0.49x

Eurofins Scientific SE (ESF0) has a Capital Reinvestment Ratio of 0.49x as of December 2022, meaning it reinvests 0% of its operating cash flow (€334.05 Million) in capital expenditures (€163.65 Million). Check tangible equity quality of Eurofins Scientific SE to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.49x
Capex / Operating Cash Flow

Operating Cash Flow

€334.05 Million
EUR

Capital Expenditures

€163.65 Million
EUR

Data as of

Dec 2022
Most recent filing

Eurofins Scientific SE Capital Reinvestment Ratio (2016–2025)

This chart tracks Eurofins Scientific SE's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see Eurofins Scientific SE (ESF0) cash conversion ratio.

Annual Capital Reinvestment Ratio for Eurofins Scientific SE (2016–2025)

Year-by-year Capital Reinvestment Ratio for Eurofins Scientific SE from 2016 to 2025. See ESF0 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2025 0.60x €1.40 Billion €834.80 Million ▲ +49.0%
2024 0.40x €1.32 Billion €528.40 Million ▼ -25.9%
2023 0.54x €1.02 Billion €550.10 Million ▲ +6.6%
2022 0.51x €1.14 Billion €576.10 Million ▲ +72.4%
2021 0.29x €1.51 Billion €444.40 Million ▲ +15.7%
2020 0.25x €1.22 Billion €310.80 Million ▼ -38.1%
2019 0.41x €677.90 Million €278.20 Million ▼ -30.7%
2018 0.59x €543.90 Million €322.20 Million ▲ +19.6%
2017 0.50x €405.12 Million €200.65 Million ▼ -7.8%
2016 0.54x €371.84 Million €199.68 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow